U.S. Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s arm -- Jubilant HollisterStier General Partnership (JHSGP)’s contract manufacturing facility located in Montreal, Canada on November 3, 2025.
The USFDA has issued 9 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations. JHSGP is jointly owned by subsidiaries of Jubilant Pharma, a wholly owned subsidiary of the company.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.
